Insiders DiaMedica Therapeutics Inc.

Equities

DMAC

CA25253X2077

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-13 pm EDT			5-day change	1st Jan Change
3.19 ^USD	+2.24%		-8.86%	+12.32%

May. 09	Transcript : DiaMedica Therapeutics Inc., Q1 2024 Earnings Call, May 09, 2024
Apr. 17	DiaMedica Therapeutics Launches Late-Stage Trial of Potential Stroke Treatment	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

DiaMedica Therapeutics Inc. Announces Executive Changes	Apr. 10	CI
DiaMedica Therapeutics Names Lorianne Masuoka as Chief Medical Officer	Jan. 22	MT
DiaMedica Therapeutics Inc. Appoints Dr. Lorianne Masuoka as Chief Medical Officer	Jan. 22	CI
DiaMedica Therapeutics Inc. Announces the Appointment of Ambarish Shah as Chief Technology Officer	23-09-12	CI
Diamedica Therapeutics Inc. Announces Management Changes	23-09-05	CI
Insider Buy: Diamedica Therapeutics	23-06-27	MT
Insider Buy: Diamedica Therapeutics	23-06-26	MT
Insider Buy: Diamedica Therapeutics	23-06-26	MT
Diamedica Therapeutics Announces Appointment of Richard Kuntz to the Board of Directors	23-05-30	CI
DiaMedica Therapeutics Appoints Tanya Lewis to its Board of Directors	23-04-16	CI
Insider Buy: Diamedica Therapeutics	23-04-11	MT
DiaMedica Therapeutics Inc. Appoints David Wambeke as Chief Business Officer	23-04-11	CI
DiaMedica Therapeutics Inc. Appoints Lewis as A Member of the Compensation Committee	23-03-10	CI
DiaMedica Therapeutics Inc. Announces Board Changes	23-03-06	CI
Diamedica Therapeutics Announces the Appointment of Tanya Lewis to its Board of Directors	23-03-06	CI
DiaMedica Therapeutics Inc. Appoints Julie Daves as Senior Vice President, Clinical Development Operations	22-09-14	CI
Insider Buy: Diamedica Therapeutics	22-07-21	MT
Diamedica Therapeutics Inc. Announces Resignation of Harry Alcorn, Jr. , Senior Vice President of Clinical Operations	22-05-25	CI
DiaMedica Therapeutics Inc. Announces the Addition of Two Key Senior Executives to the Leadership Team	22-03-14	CI
DiaMedica Therapeutics Inc. Appoints Dominic Cundari as Chief Commercial Officer	22-02-02	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders DiaMedica Therapeutics Inc.

Equities

DMAC

CA25253X2077

Insiders

Filters